{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:02:23Z","timestamp":1789624943305,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":807,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ijid.2011.01.011","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T20:20:10Z","timestamp":1300306810000},"page":"e350-e356","source":"Crossref","is-referenced-by-count":44,"title":["Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study"],"prefix":"10.1016","volume":"15","author":[{"given":"Ban Hock","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Guek Hong","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi L.","family":"Chlebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asok","family":"Kurup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foong Koon","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Tzer Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeow Tee","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Chuan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2011.01.011_bib0005","series-title":"Clinical approach to infection in the compromised host","first-page":"215","article-title":"Fungal infections in the immunocompromised host","author":"Wheat","year":"2002"},{"key":"10.1016\/j.ijid.2011.01.011_bib0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM200201243460410","article-title":"Empirical antifungal therapy\u2014new options, new tradeoffs","volume":"346","author":"Marr","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2011.01.011_bib0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2011.01.011_bib0025","doi-asserted-by":"crossref","unstructured":"EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86:668\u201372.","DOI":"10.1016\/0002-9343(89)90441-5"},{"key":"10.1016\/j.ijid.2011.01.011_bib0030","unstructured":"British Committee for Standards in Haematology. Guidelines on the management of invasive fungal infections during therapy for haematological malignancy. London: BCSH; 2008. Available at: http:\/\/www.bcshguidelines.com\/documents\/fungal_infection_bcsh_2008.pdf (accessed February 2011)."},{"key":"10.1016\/j.ijid.2011.01.011_bib0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/510677","article-title":"Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts","volume":"44","author":"Segal","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2011.01.011_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1439-0507.2008.01526.x","article-title":"Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients","volume":"51","author":"Rieger","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2011.01.011_bib0045","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0050","first-page":"1251","article-title":"Between over- and undertreatment of invasive fungal disease","volume":"45","author":"de Pauw","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0055","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2011.01.011_bib0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00001432-200312000-00002","article-title":"Impact of diagnostic markers on early antifungal therapy","volume":"16","author":"Jones","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0065","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1086\/527383","article-title":"Beta-d-glucan detection test: a step towards preemptive therapy for fungal infections in leukemic patients?","volume":"46","author":"Herbrecht","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.47102\/annals-acadmedsg.V37N1p21","article-title":"Use of antibiotics in a haematology ward\u2014an audit","volume":"37","author":"Wong","year":"2008","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.ijid.2011.01.011_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11908-008-0075-y","article-title":"Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients","volume":"10","author":"Maertens","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijid.2011.01.011_bib0085","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical and preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jac\/dkm217","article-title":"Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients","volume":"60","author":"Oshima","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.01.011_bib0095","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1086\/319225","article-title":"Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients","volume":"32","author":"Singh","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2141.2005.05727.x","article-title":"Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials","volume":"131","author":"Konstantinos","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijid.2011.01.011_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"Koh","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijid.2011.01.011_bib0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dki440","article-title":"An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia","volume":"57","author":"Glasmacher","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.01.011_bib0120","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1086\/339449","article-title":"Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant recipients: a randomized, placebo-controlled trial","volume":"185","author":"Paya","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1399-3062.2008.00325.x","article-title":"Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world view","volume":"10","author":"Tan","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0130","first-page":"1414","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"24","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0135","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.01.011_bib0140","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2002.07.004","article-title":"Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients","volume":"20","author":"Herbrecht","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijid.2011.01.011_bib0145","first-page":"266","article-title":"The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis (IPA)","volume":"44","author":"Siemann","year":"2001","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2011.01.011_bib0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","article-title":"Use of procalcitonin to shorten antibiotic treatment duration in septic patients","volume":"177","author":"Nobre","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2011.01.011_bib0155","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for biomedical research involving human subjects. Geneva: CIOMS\/WHO; 2002. Available at: http:\/\/www.cioms.ch\/publications\/layout_guide2002.pdf (accessed February 2011)."},{"key":"10.1016\/j.ijid.2011.01.011_bib0160","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections","volume":"68","author":"Ruping","year":"2008","journal-title":"Drugs"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971211000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971211000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T19:51:27Z","timestamp":1685994687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971211000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1201971211000361"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2011.01.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}